search

MaxCyte Inc (MXCT)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
Sep 23, 2026

MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer

MaxCyte, Inc. (Nasdaq: MXCT), a cell engineering company, has appointed Sidharth Kapileshwar as its new Chief Corporate Development Officer. Kapileshwar brings nearly 25 years of experience in corporate development, strategy, innovation, and M&A from major life sciences and technology companies. His appointment is expected to support MaxCyte's next phase of growth and reinforce its pioneering role in cell and gene therapies.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish